Forbion — 2013 Investments

1 investments dated 2013 · listed companies and verified rows first · show all

Allecra Therapeutics GmbHallecra.comSeries A · Apr 2013 · $20M

Antibiotic developer, maker of cefepime/enmetazobactam (EXBLIFEP).

Co-investorsAndera Partners BioMedPartners Delos Capital EMBL Ventures Xeraya Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.